UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS"

Dermata Therapeutics has received a Notice of Allowance for a U.S. patent titled 'Compositions for the Treatment of Skin Conditions.' This patent could enhance the company's position in the dermatological market. The stock ticker for Dermata Therapeutics is DRMA.